Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

APOLLO: uno studio randomizzato di fase II in doppio cieco su olaparib rispetto al placebo a seguito di terapia con intento curativo in pazienti con carcinoma pancreatico resecato e mutazione patogena BRCA1, BRCA2 o PALB2

17 novembre 2026 aggiornato da: National Cancer Institute (NCI)

This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

PRIMARY OBJECTIVE:

I. To determine the relapse-free survival (RFS) benefit from the addition of a maintenance olaparib following completion of chemotherapy in patients with resected pancreatic carcinoma and a pathogenic germline or somatic mutation in BRCA1, BRCA2 or PALB2.

SECONDARY OBJECTIVES:

I. To evaluate RFS in patients with olaparib after perioperative chemotherapy compared to those treated with perioperative therapy alone among patients who received prior platinum-based perioperative chemotherapy.

II. To evaluate overall survival (OS) in patients treated with olaparib after adjuvant chemotherapy compared to those treated with adjuvant treatment alone.

III. To analyze the efficacy of olaparib after chemotherapy in patients with a pathogenic germline BRCA or PALB2 mutation compared to those with a somatic mutation.

IV. To analyze survival differences between patients who received neoadjuvant or perioperative chemotherapy compared to those who received adjuvant therapy alone.

V. To analyze RFS and OS differences in those who received =< 3 months of perioperative platinum chemotherapy compared to those who received > 3 months of perioperative platinum chemotherapy.

VI. To analyze RFS and OS differences in those who received any platinum-based perioperative chemotherapy compared to no-platinum based perioperative chemotherapy.

EXPLORATORY OBJECTIVES:

I. To analyze RFS and OS differences in patients who had R1 versus (vs) R0 resections, lymph node positivity at resection, and/or elevated or rising CA 19-9 or CEA at time of study enrollment in the post-operative setting.

II. To analyze RFS and OS differences with those who had resectable disease at diagnosis compared to those who did not.

III. To analyze RFS and OS differences in those with gBRCA1 mutations compared to those with gBRCA2 mutations and gPALB2 mutations.

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive olaparib orally (PO) twice daily (BID) on days 1-28 of each cycle. Cycles repeat every 28 days for 12 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo computed tomography (CT) scans or CT/magnetic resonance imaging (MRI) and collection of blood throughout the study.

ARM II: Patients receive placebo PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for 12 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo CT scans or CT/MRI and collection of blood throughout the study.

After completion of study treatment, patients are followed up at 30 days, every 4 months for year 1, then every 6 months for years 2-10 after randomization.

Tipo di studio

Interventistico

Iscrizione (Stimato)

152

Fase

  • Fase 2

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Haifa, Israele, 31096
        • Sospeso
        • Rambam Medical Center
      • Dorado, Porto Rico, 00646
        • Reclutamento
        • Pan American Center for Oncology Trials LLC - Dorado
        • Investigatore principale:
          • Marcia R. Cruz-Correa
        • Contatto:
      • San Juan, Porto Rico, 00902
        • Reclutamento
        • Pan American Center for Oncology Trials LLC
        • Investigatore principale:
          • Marcia R. Cruz-Correa
        • Contatto:
    • Alaska
      • Anchorage, Alaska, Stati Uniti, 98508
        • Sospeso
        • Anchorage Associates in Radiation Medicine
      • Anchorage, Alaska, Stati Uniti, 99504
        • Sospeso
        • Anchorage Radiation Therapy Center
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Alaska Breast Care and Surgery LLC
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Alaska Oncology and Hematology LLC
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Alaska Women's Cancer Care
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Anchorage Oncology Centre
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Katmai Oncology Group
      • Anchorage, Alaska, Stati Uniti, 99508
        • Sospeso
        • Providence Alaska Medical Center
      • Fairbanks, Alaska, Stati Uniti, 99701
        • Sospeso
        • Fairbanks Memorial Hospital
    • Arizona
      • Kingman, Arizona, Stati Uniti, 86401
        • Reclutamento
        • Kingman Regional Medical Center
        • Contatto:
        • Investigatore principale:
          • Khawaja S. Jahangir
      • Phoenix, Arizona, Stati Uniti, 85004
        • Attivo, non reclutante
        • Cancer Center at Saint Joseph's
    • Arkansas
      • Fort Smith, Arkansas, Stati Uniti, 72903
        • Sospeso
        • Mercy Hospital Fort Smith
      • Hot Springs, Arkansas, Stati Uniti, 71913
        • Sospeso
        • CHI Saint Vincent Cancer Center Hot Springs
      • Jonesboro, Arkansas, Stati Uniti, 72401
        • Sospeso
        • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
    • California
      • Arroyo Grande, California, Stati Uniti, 93420
        • Sospeso
        • PCR Oncology
      • Arroyo Grande, California, Stati Uniti, 93420
        • Attivo, non reclutante
        • Mission Hope Medical Oncology - Arroyo Grande
      • Berkeley, California, Stati Uniti, 94704
        • Reclutamento
        • Alta Bates Summit Medical Center-Herrick Campus
        • Investigatore principale:
          • Ari D. Baron
        • Contatto:
      • Burbank, California, Stati Uniti, 91505
        • Sospeso
        • Providence Saint Joseph Medical Center/Disney Family Cancer Center
      • Fremont, California, Stati Uniti, 94538
      • Modesto, California, Stati Uniti, 95355
      • Mountain View, California, Stati Uniti, 94040
        • Sospeso
        • Palo Alto Medical Foundation-Gynecologic Oncology
      • Orange, California, Stati Uniti, 92868
        • Reclutamento
        • Saint Joseph Hospital - Orange
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 714-734-6220
        • Investigatore principale:
          • Timothy E. Byun
      • Roseville, California, Stati Uniti, 95661
      • Sacramento, California, Stati Uniti, 95816
      • San Francisco, California, Stati Uniti, 94115
        • Reclutamento
        • California Pacific Medical Center-Pacific Campus
        • Investigatore principale:
          • Ari D. Baron
        • Contatto:
      • San Luis Obispo, California, Stati Uniti, 93401
        • Attivo, non reclutante
        • Pacific Central Coast Health Center-San Luis Obispo
      • San Mateo, California, Stati Uniti, 94401
      • Santa Cruz, California, Stati Uniti, 95065
      • Santa Maria, California, Stati Uniti, 93444
        • Attivo, non reclutante
        • Mission Hope Medical Oncology - Santa Maria
      • Santa Rosa, California, Stati Uniti, 95403
        • Reclutamento
        • Sutter Pacific Medical Foundation
        • Investigatore principale:
          • Ari D. Baron
        • Contatto:
      • Santa Rosa, California, Stati Uniti, 95403
        • Reclutamento
        • Providence Medical Foundation - Santa Rosa
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 707-521-3830
      • Santa Rosa, California, Stati Uniti, 95405
        • Sospeso
        • Providence Santa Rosa Memorial Hospital
      • Sunnyvale, California, Stati Uniti, 94086
      • Vacaville, California, Stati Uniti, 95687
        • Reclutamento
        • Northbay Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 707-624-8007
        • Investigatore principale:
          • Brian G. Vikstrom
    • Colorado
      • Colorado Springs, Colorado, Stati Uniti, 80907
        • Attivo, non reclutante
        • Penrose-Saint Francis Healthcare
      • Colorado Springs, Colorado, Stati Uniti, 80907
        • Attivo, non reclutante
        • Rocky Mountain Cancer Centers-Penrose
      • Denver, Colorado, Stati Uniti, 80210
        • Sospeso
        • AdventHealth Porter
      • Durango, Colorado, Stati Uniti, 81301
        • Attivo, non reclutante
        • Mercy Medical Center
      • Durango, Colorado, Stati Uniti, 81301
        • Attivo, non reclutante
        • CommonSpirit Cancer Center Mercy
      • Lakewood, Colorado, Stati Uniti, 80228
        • Attivo, non reclutante
        • CommonSpirit Saint Anthony Hospital Cancer Center
      • Littleton, Colorado, Stati Uniti, 80122
        • Sospeso
        • AdventHealth Littleton
      • Longmont, Colorado, Stati Uniti, 80501
        • Attivo, non reclutante
        • Longmont United Hospital
      • Longmont, Colorado, Stati Uniti, 80501
        • Attivo, non reclutante
        • Rocky Mountain Cancer Centers-Longmont
      • Parker, Colorado, Stati Uniti, 80138
        • Sospeso
        • AdventHealth Parker
      • Pueblo, Colorado, Stati Uniti, 81004
        • Attivo, non reclutante
        • Saint Mary Corwin Medical Center
    • District of Columbia
      • Washington D.C., District of Columbia, Stati Uniti, 20016
        • Reclutamento
        • Sibley Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Michael J. Pishvaian
    • Florida
      • Altamonte Springs, Florida, Stati Uniti, 32701
        • Reclutamento
        • AdventHealth Altamonte
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 407-303-2200
        • Investigatore principale:
          • Mohamedtaki A. Tejani
      • Celebration, Florida, Stati Uniti, 34747
        • Sospeso
        • AdventHealth Celebration
      • Coral Gables, Florida, Stati Uniti, 33146
        • Reclutamento
        • UM Sylvester Comprehensive Cancer Center at Coral Gables
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 305-243-2647
        • Investigatore principale:
          • Nkiruka Ezenwajiaku
      • Deerfield Beach, Florida, Stati Uniti, 33442
        • Reclutamento
        • UM Sylvester Comprehensive Cancer Center at Deerfield Beach
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 305-243-2647
        • Investigatore principale:
          • Nkiruka Ezenwajiaku
      • Kissimmee, Florida, Stati Uniti, 34744
        • Sospeso
        • AdventHealth Kissimmee
      • Miami, Florida, Stati Uniti, 33136
        • Reclutamento
        • University of Miami Miller School of Medicine-Sylvester Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 305-243-2647
        • Investigatore principale:
          • Nkiruka Ezenwajiaku
      • Miami, Florida, Stati Uniti, 33176
        • Reclutamento
        • UM Sylvester Comprehensive Cancer Center at Kendall
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 305-243-2647
        • Investigatore principale:
          • Nkiruka Ezenwajiaku
      • Orlando, Florida, Stati Uniti, 32803
        • Sospeso
        • AdventHealth Medical Group Urology at Orlando
      • Orlando, Florida, Stati Uniti, 32803
        • Reclutamento
        • AdventHealth Orlando
        • Contatto:
        • Investigatore principale:
          • Mohamedtaki A. Tejani
      • Orlando, Florida, Stati Uniti, 32822
        • Sospeso
        • AdventHealth East Orlando
      • Plantation, Florida, Stati Uniti, 33324
        • Reclutamento
        • UM Sylvester Comprehensive Cancer Center at Plantation
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 305-243-2647
        • Investigatore principale:
          • Nkiruka Ezenwajiaku
      • Winter Park, Florida, Stati Uniti, 32792
        • Sospeso
        • AdventHealth Winter Park
    • Georgia
      • Atlanta, Georgia, Stati Uniti, 30308
        • Attivo, non reclutante
        • Emory University Hospital Midtown
      • Atlanta, Georgia, Stati Uniti, 30322
        • Attivo, non reclutante
        • Emory University Hospital/Winship Cancer Institute
      • Atlanta, Georgia, Stati Uniti, 30342
        • Attivo, non reclutante
        • Emory Saint Joseph's Hospital
    • Hawaii
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Hawaii Cancer Care Inc - Waterfront Plaza
        • Contatto:
        • Investigatore principale:
          • Jared D. Acoba
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Queen's Cancer Cenrer - POB I
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-532-0315
        • Investigatore principale:
          • Jared D. Acoba
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Queen's Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-545-8548
        • Investigatore principale:
          • Jared D. Acoba
      • Honolulu, Hawaii, Stati Uniti, 96813
        • Reclutamento
        • Straub Clinic and Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-522-4333
        • Investigatore principale:
          • Jared D. Acoba
      • Honolulu, Hawaii, Stati Uniti, 96817
        • Reclutamento
        • Queen's Cancer Center - Kuakini
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-531-8521
        • Investigatore principale:
          • Jared D. Acoba
      • ‘Aiea, Hawaii, Stati Uniti, 96701
        • Reclutamento
        • Hawaii Cancer Care - Westridge
        • Contatto:
        • Investigatore principale:
          • Jared D. Acoba
      • ‘Aiea, Hawaii, Stati Uniti, 96701
        • Reclutamento
        • Pali Momi Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 808-486-6000
        • Investigatore principale:
          • Jared D. Acoba
      • ‘Ewa Beach, Hawaii, Stati Uniti, 96706
        • Reclutamento
        • The Queen's Medical Center - West Oahu
        • Contatto:
        • Investigatore principale:
          • Jared D. Acoba
    • Idaho
      • Boise, Idaho, Stati Uniti, 83712
        • Reclutamento
        • Saint Luke's Cancer Institute - Boise
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Boise, Idaho, Stati Uniti, 83706
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Boise
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Coeur d'Alene, Idaho, Stati Uniti, 83814
        • Reclutamento
        • Kootenai Health - Coeur d'Alene
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Fruitland, Idaho, Stati Uniti, 83619
        • Reclutamento
        • Saint Luke's Cancer Institute - Fruitland
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Meridian, Idaho, Stati Uniti, 83642
        • Reclutamento
        • Saint Luke's Cancer Institute - Meridian
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Nampa, Idaho, Stati Uniti, 83687
        • Reclutamento
        • Saint Luke's Cancer Institute - Nampa
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Nampa, Idaho, Stati Uniti, 83687
        • Reclutamento
        • Saint Alphonsus Cancer Care Center-Nampa
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Post Falls, Idaho, Stati Uniti, 83854
        • Reclutamento
        • Kootenai Clinic Cancer Services - Post Falls
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Sandpoint, Idaho, Stati Uniti, 83864
        • Reclutamento
        • Kootenai Clinic Cancer Services - Sandpoint
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Twin Falls, Idaho, Stati Uniti, 83301
        • Reclutamento
        • Saint Luke's Cancer Institute - Twin Falls
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
    • Illinois
      • Alton, Illinois, Stati Uniti, 62002
        • Sospeso
        • OSF Saint Anthony's Health Center
      • Aurora, Illinois, Stati Uniti, 60504
        • Sospeso
        • Rush-Copley Medical Center
      • Bloomington, Illinois, Stati Uniti, 61704
        • Reclutamento
        • Illinois CancerCare-Bloomington
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Canton, Illinois, Stati Uniti, 61520
        • Reclutamento
        • Illinois CancerCare-Canton
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Carbondale, Illinois, Stati Uniti, 62902
        • Sospeso
        • Memorial Hospital of Carbondale
      • Carterville, Illinois, Stati Uniti, 62918
        • Sospeso
        • SIH Cancer Institute
      • Carthage, Illinois, Stati Uniti, 62321
        • Reclutamento
        • Illinois CancerCare-Carthage
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Centralia, Illinois, Stati Uniti, 62801
        • Reclutamento
        • Centralia Oncology Clinic
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Chicago, Illinois, Stati Uniti, 60637
        • Reclutamento
        • University of Chicago Comprehensive Cancer Center
        • Contatto:
        • Investigatore principale:
          • Ardaman Shergill
      • Chicago, Illinois, Stati Uniti, 60612
        • Reclutamento
        • University of Illinois
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 312-355-3046
        • Investigatore principale:
          • Shikha Jain
      • Danville, Illinois, Stati Uniti, 61832
        • Reclutamento
        • Carle at The Riverfront
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Decatur, Illinois, Stati Uniti, 62526
        • Reclutamento
        • Cancer Care Specialists of Illinois - Decatur
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Decatur, Illinois, Stati Uniti, 62526
        • Reclutamento
        • Decatur Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Dixon, Illinois, Stati Uniti, 61021
        • Reclutamento
        • Illinois CancerCare-Dixon
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 815-285-7800
      • Effingham, Illinois, Stati Uniti, 62401
        • Reclutamento
        • Carle Physician Group-Effingham
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Effingham, Illinois, Stati Uniti, 62401
        • Reclutamento
        • Crossroads Cancer Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Elmhurst, Illinois, Stati Uniti, 60126
        • Reclutamento
        • Elmhurst Memorial Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 630-758-5460
          • Email: Jrohde@emhc.org
        • Investigatore principale:
          • Hollis Walker
      • Eureka, Illinois, Stati Uniti, 61530
        • Reclutamento
        • Illinois CancerCare-Eureka
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Galesburg, Illinois, Stati Uniti, 61401
        • Reclutamento
        • Illinois CancerCare-Galesburg
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Galesburg, Illinois, Stati Uniti, 61401
        • Sospeso
        • Western Illinois Cancer Treatment Center
      • Kewanee, Illinois, Stati Uniti, 61443
        • Reclutamento
        • Illinois CancerCare-Kewanee Clinic
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Macomb, Illinois, Stati Uniti, 61455
        • Reclutamento
        • Illinois CancerCare-Macomb
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Mattoon, Illinois, Stati Uniti, 61938
        • Reclutamento
        • Carle Physician Group-Mattoon/Charleston
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Mount Vernon, Illinois, Stati Uniti, 62864
        • Sospeso
        • SSM Health Good Samaritan
      • Naperville, Illinois, Stati Uniti, 60540
        • Reclutamento
        • Edward Hospital/Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 630-646-6075
        • Investigatore principale:
          • Hollis Walker
      • New Lenox, Illinois, Stati Uniti, 60451
        • Reclutamento
        • UC Comprehensive Cancer Center at Silver Cross
        • Contatto:
        • Investigatore principale:
          • Ardaman Shergill
      • O'Fallon, Illinois, Stati Uniti, 62269
        • Reclutamento
        • Cancer Care Center of O'Fallon
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Orland Park, Illinois, Stati Uniti, 60462
        • Reclutamento
        • University of Chicago Medicine-Orland Park
        • Contatto:
        • Investigatore principale:
          • Ardaman Shergill
      • Ottawa, Illinois, Stati Uniti, 61350
        • Reclutamento
        • Illinois CancerCare-Ottawa Clinic
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Pekin, Illinois, Stati Uniti, 61554
        • Reclutamento
        • Illinois CancerCare-Pekin
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peoria, Illinois, Stati Uniti, 61615
        • Reclutamento
        • Illinois CancerCare-Peoria
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peoria, Illinois, Stati Uniti, 61636
        • Sospeso
        • Methodist Medical Center of Illinois
      • Peru, Illinois, Stati Uniti, 61354
        • Reclutamento
        • Illinois CancerCare-Peru
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Peru, Illinois, Stati Uniti, 61354
        • Sospeso
        • Valley Radiation Oncology
      • Plainfield, Illinois, Stati Uniti, 60585
        • Reclutamento
        • Edward Hospital/Cancer Center?Plainfield
        • Contatto:
        • Investigatore principale:
          • Hollis Walker
      • Princeton, Illinois, Stati Uniti, 61356
        • Reclutamento
        • Illinois CancerCare-Princeton
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Springfield, Illinois, Stati Uniti, 62702
        • Reclutamento
        • Southern Illinois University School of Medicine
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 217-545-7929
      • Springfield, Illinois, Stati Uniti, 62702
        • Reclutamento
        • Springfield Clinic
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 800-444-7541
      • Springfield, Illinois, Stati Uniti, 62781
        • Reclutamento
        • Springfield Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
      • Urbana, Illinois, Stati Uniti, 61801
        • Reclutamento
        • Carle Cancer Center
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Urbana, Illinois, Stati Uniti, 61801
        • Sospeso
        • The Carle Foundation Hospital
      • Washington, Illinois, Stati Uniti, 61571
        • Reclutamento
        • Illinois CancerCare - Washington
        • Contatto:
        • Investigatore principale:
          • Bryan A. Faller
      • Yorkville, Illinois, Stati Uniti, 60560
        • Sospeso
        • Rush-Copley Healthcare Center
    • Indiana
      • Carmel, Indiana, Stati Uniti, 46032
        • Attivo, non reclutante
        • IU Health North Hospital
      • Crown Point, Indiana, Stati Uniti, 46307
        • Reclutamento
        • Northwest Cancer Center - Crown Point
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Dyer, Indiana, Stati Uniti, 46311
        • Reclutamento
        • Northwest Oncology LLC
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 219-924-8178
      • Hobart, Indiana, Stati Uniti, 46342
        • Reclutamento
        • Saint Mary Medical Center
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
      • Indianapolis, Indiana, Stati Uniti, 46202
        • Attivo, non reclutante
        • Indiana University/Melvin and Bren Simon Cancer Center
      • Munster, Indiana, Stati Uniti, 46321
        • Reclutamento
        • The Community Hospital
        • Investigatore principale:
          • Suparna Mantha
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 219-836-3349
      • South Bend, Indiana, Stati Uniti, 46601
        • Attivo, non reclutante
        • Memorial Hospital of South Bend
    • Iowa
      • Ames, Iowa, Stati Uniti, 50010
        • Reclutamento
        • Mary Greeley Medical Center
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-956-4132
      • Ames, Iowa, Stati Uniti, 50010
        • Reclutamento
        • McFarland Clinic - Ames
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
      • Ankeny, Iowa, Stati Uniti, 50023
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Ankeny Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Boone, Iowa, Stati Uniti, 50036
        • Sospeso
        • McFarland Clinic - Boone
      • Carroll, Iowa, Stati Uniti, 51401
        • Reclutamento
        • Saint Anthony Regional Hospital
        • Contatto:
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Clive, Iowa, Stati Uniti, 50325
        • Reclutamento
        • Mercy Cancer Center-West Lakes
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
      • Clive, Iowa, Stati Uniti, 50325
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - West Des Moines Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Council Bluffs, Iowa, Stati Uniti, 51503
        • Sospeso
        • Heartland Oncology and Hematology LLP
      • Council Bluffs, Iowa, Stati Uniti, 51503
        • Attivo, non reclutante
        • Alegent Health Mercy Hospital
      • Council Bluffs, Iowa, Stati Uniti, 51503
        • Sospeso
        • Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ
      • Creston, Iowa, Stati Uniti, 50801
        • Attivo, non reclutante
        • Greater Regional Medical Center
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • Broadlawns Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-282-2200
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • Mercy Medical Center - Des Moines
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
      • Des Moines, Iowa, Stati Uniti, 50316
        • Sospeso
        • Iowa Lutheran Hospital
      • Des Moines, Iowa, Stati Uniti, 50309
        • Reclutamento
        • Iowa Methodist Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-6727
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50309
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Des Moines Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Des Moines, Iowa, Stati Uniti, 50314
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Laurel Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • Fort Dodge, Iowa, Stati Uniti, 50501
        • Reclutamento
        • McFarland Clinic - Trinity Cancer Center
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-956-4132
      • Fort Dodge, Iowa, Stati Uniti, 50501
        • Reclutamento
        • UI Healthcare Mission Cancer and Blood - Fort Dodge
        • Investigatore principale:
          • Seema Harichand-Herdt
        • Contatto:
      • Jefferson, Iowa, Stati Uniti, 50129
        • Sospeso
        • McFarland Clinic - Jefferson
      • Marshalltown, Iowa, Stati Uniti, 50158
        • Reclutamento
        • McFarland Clinic - Marshalltown
        • Investigatore principale:
          • Joseph J. Merchant
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-956-4132
      • Waukee, Iowa, Stati Uniti, 50263
        • Reclutamento
        • UI Health Care Mission Cancer and Blood - Waukee Clinic
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Seema Harichand-Herdt
      • West Des Moines, Iowa, Stati Uniti, 50266-7700
        • Sospeso
        • Methodist West Hospital
      • West Des Moines, Iowa, Stati Uniti, 50266
        • Reclutamento
        • Mercy Medical Center-West Lakes
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 515-241-3305
        • Investigatore principale:
          • Richard L. Deming
    • Kansas
      • Fairway, Kansas, Stati Uniti, 66205
        • Sospeso
        • University of Kansas Clinical Research Center
      • Garden City, Kansas, Stati Uniti, 67846
        • Sospeso
        • Central Care Cancer Center - Garden City
      • Great Bend, Kansas, Stati Uniti, 67530
        • Sospeso
        • Central Care Cancer Center - Great Bend
      • Hays, Kansas, Stati Uniti, 67601
        • Reclutamento
        • HaysMed
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 785-623-5774
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Kansas City, Kansas, Stati Uniti, 66160
        • Reclutamento
        • University of Kansas Cancer Center
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Lawrence, Kansas, Stati Uniti, 66044
        • Reclutamento
        • Lawrence Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Olathe, Kansas, Stati Uniti, 66061
        • Reclutamento
        • The University of Kansas Cancer Center - Olathe
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
        • Contatto:
      • Overland Park, Kansas, Stati Uniti, 66211
        • Reclutamento
        • University of Kansas Hospital-Indian Creek Campus
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Overland Park, Kansas, Stati Uniti, 66210
        • Reclutamento
        • University of Kansas Cancer Center-Overland Park
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Pittsburg, Kansas, Stati Uniti, 66762
        • Reclutamento
        • Freeman Physician Group of Pittsburg
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Pittsburg, Kansas, Stati Uniti, 66762
        • Sospeso
        • Mercy Hospital Pittsburg
      • Salina, Kansas, Stati Uniti, 67401
        • Reclutamento
        • Salina Regional Health Center
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Topeka, Kansas, Stati Uniti, 66606
        • Reclutamento
        • University of Kansas Health System Saint Francis Campus
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 785-295-8000
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Westwood, Kansas, Stati Uniti, 66205
        • Reclutamento
        • University of Kansas Hospital-Westwood Cancer Center
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
    • Kentucky
      • Bardstown, Kentucky, Stati Uniti, 40004
        • Attivo, non reclutante
        • CommonSpirit Saint Joseph Hospital - Bardstown
      • Corbin, Kentucky, Stati Uniti, 40701
        • Attivo, non reclutante
        • Commonwealth Cancer Center-Corbin
      • Lexington, Kentucky, Stati Uniti, 40504
        • Attivo, non reclutante
        • Saint Joseph Radiation Oncology Resource Center
      • Lexington, Kentucky, Stati Uniti, 40509
        • Attivo, non reclutante
        • CommonSpirit Saint Joseph Medical Center - East Lexington
      • London, Kentucky, Stati Uniti, 40741
        • Attivo, non reclutante
        • CommonSpirit Saint Joseph Hospital London
      • Louisville, Kentucky, Stati Uniti, 40202
        • Sospeso
        • Jewish Hospital
      • Louisville, Kentucky, Stati Uniti, 40215
        • Sospeso
        • Saints Mary and Elizabeth Hospital
      • Louisville, Kentucky, Stati Uniti, 40245
        • Sospeso
        • UofL Health Medical Center Northeast
      • Shepherdsville, Kentucky, Stati Uniti, 40165
        • Attivo, non reclutante
        • Jewish Hospital Medical Center South
    • Louisiana
      • Baton Rouge, Louisiana, Stati Uniti, 70809
        • Reclutamento
        • Louisiana Hematology Oncology Associates LLC
        • Contatto:
        • Investigatore principale:
          • William T. Varnado
      • Baton Rouge, Louisiana, Stati Uniti, 70809
        • Reclutamento
        • Mary Bird Perkins Cancer Center
        • Contatto:
        • Investigatore principale:
          • William T. Varnado
      • Covington, Louisiana, Stati Uniti, 70433
        • Attivo, non reclutante
        • Ochsner Hematology Oncology North Shore - Covington (West Region)
      • New Orleans, Louisiana, Stati Uniti, 70121
        • Attivo, non reclutante
        • Ochsner Medical Center Jefferson
    • Michigan
      • Adrian, Michigan, Stati Uniti, 49221
        • Sospeso
        • Hickman Cancer Center
      • Ann Arbor, Michigan, Stati Uniti, 48109
        • Reclutamento
        • University of Michigan Rogel Cancer Center
        • Investigatore principale:
          • Thomas Enzler
        • Contatto:
      • Ann Arbor, Michigan, Stati Uniti, 48106
        • Reclutamento
        • Trinity Health Saint Joseph Mercy Hospital Ann Arbor
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Brighton, Michigan, Stati Uniti, 48114
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Brighton
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Brighton, Michigan, Stati Uniti, 48114
        • Reclutamento
        • Trinity Health Medical Center - Brighton
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Canton, Michigan, Stati Uniti, 48188
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Canton
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Canton, Michigan, Stati Uniti, 48188
        • Reclutamento
        • Trinity Health Medical Center - Canton
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Chelsea, Michigan, Stati Uniti, 48118
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Chelsea, Michigan, Stati Uniti, 48118
      • Clarkston, Michigan, Stati Uniti, 48346
        • Reclutamento
        • Hematology Oncology Consultants-Clarkston
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Clarkston, Michigan, Stati Uniti, 48346
        • Sospeso
        • Newland Medical Associates-Clarkston
      • Dearborn, Michigan, Stati Uniti, 48124
        • Reclutamento
        • Corewell Health Dearborn Hospital
        • Investigatore principale:
          • Dana Zakalik
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-551-7695
      • Detroit, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Health Saint John Hospital
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • East China Township, Michigan, Stati Uniti, 48054
        • Reclutamento
        • Henry Ford River District Hospital
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Farmington Hills, Michigan, Stati Uniti, 48336
        • Sospeso
        • Corewell Health Farmington Hills Hospital
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Genesys Hurley Cancer Institute
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Flint, Michigan, Stati Uniti, 48503
        • Sospeso
        • Genesee Hematology Oncology PC
      • Flint, Michigan, Stati Uniti, 48503
        • Reclutamento
        • Cancer Hematology Centers - Flint
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Grosse Pointe Woods, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Saint John Hospital - Academic
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Grosse Pointe Woods, Michigan, Stati Uniti, 48236
        • Reclutamento
        • Henry Ford Saint John Hospital - Van Elslander
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Livonia, Michigan, Stati Uniti, 48154
        • Reclutamento
        • Trinity Health Saint Mary Mercy Livonia Hospital
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Macomb, Michigan, Stati Uniti, 48044
        • Reclutamento
        • Henry Ford Saint John Hospital - Macomb Medical
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Monroe, Michigan, Stati Uniti, 48162
        • Sospeso
        • Toledo Clinic Cancer Centers-Monroe
      • Novi, Michigan, Stati Uniti, 48374
        • Reclutamento
        • Henry Ford Health Providence Novi Hospital
        • Investigatore principale:
          • Susan E. Lyons
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-849-5332
          • Email: kfife3@hfhs.org
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Trinity Health Saint Joseph Mercy Oakland Hospital
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Michigan Healthcare Professionals Pontiac
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Pontiac, Michigan, Stati Uniti, 48341
        • Reclutamento
        • Trinity Health IHA Medical Group-Alice Gustafson Center
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Royal Oak, Michigan, Stati Uniti, 48073
        • Reclutamento
        • Corewell Health William Beaumont University Hospital
        • Investigatore principale:
          • Dana Zakalik
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-551-7695
      • Saginaw, Michigan, Stati Uniti, 48604
        • Sospeso
        • Oncology Hematology Associates of Saginaw Valley PC
      • Saginaw, Michigan, Stati Uniti, 48601
        • Reclutamento
        • MyMichigan Medical Center Saginaw
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Southfield, Michigan, Stati Uniti, 48075
        • Reclutamento
        • Henry Ford Health Providence Southfield Hospital
        • Investigatore principale:
          • Susan E. Lyons
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-849-5332
          • Email: kfife3@hfhs.org
      • Sterling Heights, Michigan, Stati Uniti, 48312
        • Sospeso
        • Bhadresh Nayak MD PC-Sterling Heights
      • Tawas City, Michigan, Stati Uniti, 48764
        • Reclutamento
        • MyMichigan Medical Center Tawas
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Troy, Michigan, Stati Uniti, 48085
        • Reclutamento
        • Corewell Health Beaumont Troy Hospital
        • Investigatore principale:
          • Dana Zakalik
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 248-551-7695
      • Warren, Michigan, Stati Uniti, 48093
        • Reclutamento
        • Henry Ford Health Warren Hospital
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • Warren, Michigan, Stati Uniti, 48093
        • Reclutamento
        • Henry Ford Warren Hospital - GLCMS
        • Investigatore principale:
          • Christopher M. Reynolds
        • Contatto:
      • West Branch, Michigan, Stati Uniti, 48661
        • Sospeso
        • Saint Mary's Oncology/Hematology Associates of West Branch
      • Ypsilanti, Michigan, Stati Uniti, 48106
        • Reclutamento
        • Huron Gastroenterology PC
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
      • Ypsilanti, Michigan, Stati Uniti, 48197
        • Reclutamento
        • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
        • Contatto:
        • Investigatore principale:
          • Christopher M. Reynolds
    • Minnesota
      • Bemidji, Minnesota, Stati Uniti, 56601
      • Coon Rapids, Minnesota, Stati Uniti, 55433
        • Reclutamento
        • Mercy Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Duluth, Minnesota, Stati Uniti, 55805
        • Reclutamento
        • Saint Luke's Hospital of Duluth
        • Contatto:
        • Investigatore principale:
          • Homam Alkaied
      • Minneapolis, Minnesota, Stati Uniti, 55407
        • Reclutamento
        • Abbott-Northwestern Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Rochester, Minnesota, Stati Uniti, 55905
        • Attivo, non reclutante
        • Mayo Clinic in Rochester
      • Saint Louis Park, Minnesota, Stati Uniti, 55416
        • Reclutamento
        • Park Nicollet Clinic - Saint Louis Park
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Paul, Minnesota, Stati Uniti, 55101
        • Reclutamento
        • Regions Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Saint Paul, Minnesota, Stati Uniti, 55102
        • Reclutamento
        • United Hospital
        • Contatto:
        • Investigatore principale:
          • David M. King
    • Mississippi
      • Columbus, Mississippi, Stati Uniti, 39705
        • Reclutamento
        • Baptist Memorial Hospital and Cancer Center-Golden Triangle
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
      • Grenada, Mississippi, Stati Uniti, 38901
        • Reclutamento
        • Baptist Cancer Center-Grenada
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
      • New Albany, Mississippi, Stati Uniti, 38652
        • Reclutamento
        • Baptist Memorial Hospital and Cancer Center-Union County
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
      • Oxford, Mississippi, Stati Uniti, 38655
        • Reclutamento
        • Baptist Memorial Hospital and Cancer Center-Oxford
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
      • Southhaven, Mississippi, Stati Uniti, 38671
        • Reclutamento
        • Baptist Memorial Hospital and Cancer Center-Desoto
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
    • Missouri
      • Ballwin, Missouri, Stati Uniti, 63011
        • Reclutamento
        • Mercy Oncology and Hematology - Clayton-Clarkson
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 888-446-3729
      • Bolivar, Missouri, Stati Uniti, 65613
        • Sospeso
        • Central Care Cancer Center - Bolivar
      • Cape Girardeau, Missouri, Stati Uniti, 63703
        • Reclutamento
        • Saint Francis Medical Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 573-334-2230
          • Email: sfmc@sfmc.net
      • Cape Girardeau, Missouri, Stati Uniti, 63703
        • Sospeso
        • Mercy Cancer Center - Cape Girardeau
      • Farmington, Missouri, Stati Uniti, 63640
        • Reclutamento
        • Parkland Health Center - Farmington
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Jefferson City, Missouri, Stati Uniti, 65109
        • Sospeso
        • MU Health Care Goldschmidt Cancer Center
      • Joplin, Missouri, Stati Uniti, 64804
        • Sospeso
        • Freeman Health System
      • Joplin, Missouri, Stati Uniti, 64804
        • Sospeso
        • Mercy Hospital Joplin
      • Kansas City, Missouri, Stati Uniti, 64111
        • Reclutamento
        • Saint Luke's Hospital of Kansas City
        • Contatto:
        • Investigatore principale:
          • Marc T. Roth
      • Kansas City, Missouri, Stati Uniti, 64154
        • Reclutamento
        • University of Kansas Cancer Center - North
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Kansas City, Missouri, Stati Uniti, 64108
        • Reclutamento
        • University Health Truman Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 816-404-4375
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Lee's Summit, Missouri, Stati Uniti, 64064
        • Reclutamento
        • University of Kansas Cancer Center - Lee's Summit
        • Contatto:
        • Investigatore principale:
          • Anup K. Kasi Loknath Kumar
      • Lee's Summit, Missouri, Stati Uniti, 64086
        • Reclutamento
        • Saint Luke's East - Lee's Summit
        • Contatto:
        • Investigatore principale:
          • Marc T. Roth
      • North Kansas City, Missouri, Stati Uniti, 64116
        • Sospeso
        • University of Kansas Cancer Center at North Kansas City Hospital
      • Rolla, Missouri, Stati Uniti, 65401
        • Sospeso
        • Mercy Clinic-Rolla-Cancer and Hematology
      • Rolla, Missouri, Stati Uniti, 65401
        • Sospeso
        • Phelps Health Delbert Day Cancer Institute
      • Saint Joseph, Missouri, Stati Uniti, 64506
        • Sospeso
        • Heartland Regional Medical Center
      • Sainte Genevieve, Missouri, Stati Uniti, 63670
        • Reclutamento
        • Sainte Genevieve County Memorial Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Springfield, Missouri, Stati Uniti, 65804
        • Reclutamento
        • Mercy Hospital Springfield
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 417-269-4520
      • Springfield, Missouri, Stati Uniti, 65807
        • Sospeso
        • CoxHealth South Hospital
      • St Louis, Missouri, Stati Uniti, 63128
        • Reclutamento
        • Mercy Hospital South
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
      • St Louis, Missouri, Stati Uniti, 63141
        • Reclutamento
        • Mercy Hospital Saint Louis
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-251-7066
      • St Louis, Missouri, Stati Uniti, 63109
        • Sospeso
        • Mercy Infusion Center - Chippewa
      • St Louis, Missouri, Stati Uniti, 63131
        • Reclutamento
        • Missouri Baptist Medical Center
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Sullivan, Missouri, Stati Uniti, 63080
        • Reclutamento
        • Missouri Baptist Sullivan Hospital
        • Investigatore principale:
          • Bryan A. Faller
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 314-996-5569
      • Washington, Missouri, Stati Uniti, 63090
        • Sospeso
        • Mercy Hospital Washington
    • Montana
      • Anaconda, Montana, Stati Uniti, 59711
        • Reclutamento
        • Community Hospital of Anaconda
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Billings, Montana, Stati Uniti, 59101
        • Reclutamento
        • Billings Clinic Cancer Center
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Bozeman, Montana, Stati Uniti, 59715
        • Reclutamento
        • Bozeman Health Deaconess Hospital
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Great Falls, Montana, Stati Uniti, 59405
        • Reclutamento
        • Benefis Sletten Cancer Institute
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Kalispell, Montana, Stati Uniti, 59901
        • Reclutamento
        • Logan Health Medical Center
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
      • Missoula, Montana, Stati Uniti, 59802
        • Sospeso
        • Saint Patrick Hospital - Community Hospital
      • Missoula, Montana, Stati Uniti, 59804
        • Reclutamento
        • Community Medical Center
        • Investigatore principale:
          • John M. Schallenkamp
        • Contatto:
    • Nebraska
      • Grand Island, Nebraska, Stati Uniti, 68803
        • Sospeso
        • Nebraska Cancer Specialists/Oncology Hematology West PC
      • Kearney, Nebraska, Stati Uniti, 68847
        • Attivo, non reclutante
        • CHI Health Good Samaritan
      • Lincoln, Nebraska, Stati Uniti, 68510
        • Attivo, non reclutante
        • Saint Elizabeth Regional Medical Center
      • Omaha, Nebraska, Stati Uniti, 68122
        • Attivo, non reclutante
        • Alegent Health Immanuel Medical Center
      • Omaha, Nebraska, Stati Uniti, 68124
        • Attivo, non reclutante
        • Alegent Health Bergan Mercy Medical Center
      • Omaha, Nebraska, Stati Uniti, 68130
        • Attivo, non reclutante
        • Alegent Health Lakeside Hospital
      • Omaha, Nebraska, Stati Uniti, 68114
        • Sospeso
        • Nebraska Methodist Hospital
      • Omaha, Nebraska, Stati Uniti, 68114
        • Sospeso
        • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
      • Papillion, Nebraska, Stati Uniti, 68046
        • Attivo, non reclutante
        • Midlands Community Hospital
    • Nevada
      • Carson City, Nevada, Stati Uniti, 89703
        • Sospeso
        • Carson Tahoe Regional Medical Center
      • Henderson, Nevada, Stati Uniti, 89052
        • Sospeso
        • Cancer and Blood Specialists-Henderson
      • Henderson, Nevada, Stati Uniti, 89052
        • Sospeso
        • Comprehensive Cancer Centers of Nevada - Henderson
      • Henderson, Nevada, Stati Uniti, 89052
        • Sospeso
        • Comprehensive Cancer Centers of Nevada-Horizon Ridge
      • Henderson, Nevada, Stati Uniti, 89052
        • Sospeso
        • Las Vegas Cancer Center-Henderson
      • Henderson, Nevada, Stati Uniti, 89074
        • Sospeso
        • Comprehensive Cancer Centers of Nevada-Southeast Henderson
      • Henderson, Nevada, Stati Uniti, 89074
        • Sospeso
        • Las Vegas Urology - Green Valley
      • Henderson, Nevada, Stati Uniti, 89074
        • Sospeso
        • Las Vegas Urology - Pebble
      • Henderson, Nevada, Stati Uniti, 89074
        • Sospeso
        • Urology Specialists of Nevada - Green Valley
      • Henderson, Nevada, Stati Uniti, 89074
        • Sospeso
        • Oncology Las Vegas - Henderson
      • Las Vegas, Nevada, Stati Uniti, 89102
        • Sospeso
        • Desert West Surgery
      • Las Vegas, Nevada, Stati Uniti, 89102
        • Reclutamento
        • OptumCare Cancer Care at Charleston
        • Contatto:
        • Investigatore principale:
          • Khawaja S. Jahangir
      • Las Vegas, Nevada, Stati Uniti, 89074
        • Sospeso
        • Las Vegas Urology - Pecos
      • Las Vegas, Nevada, Stati Uniti, 89102
        • Sospeso
        • University Medical Center of Southern Nevada
      • Las Vegas, Nevada, Stati Uniti, 89103
        • Sospeso
        • Hope Cancer Care of Nevada
      • Las Vegas, Nevada, Stati Uniti, 89106
        • Sospeso
        • Radiation Oncology Centers of Nevada Central
      • Las Vegas, Nevada, Stati Uniti, 89106
        • Sospeso
        • Urology Specialists of Nevada - Central
      • Las Vegas, Nevada, Stati Uniti, 89109
        • Sospeso
        • Sunrise Hospital and Medical Center
      • Las Vegas, Nevada, Stati Uniti, 89113
        • Sospeso
        • Las Vegas Prostate Cancer Center
      • Las Vegas, Nevada, Stati Uniti, 89113
        • Sospeso
        • Las Vegas Urology - Sunset
      • Las Vegas, Nevada, Stati Uniti, 89113
        • Sospeso
        • Urology Specialists of Nevada - Southwest
      • Las Vegas, Nevada, Stati Uniti, 89119
        • Sospeso
        • Radiation Oncology Centers of Nevada Southeast
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • Ann M Wierman MD LTD
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • Comprehensive Cancer Centers of Nevada - Northwest
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • Las Vegas Urology - Cathedral Rock
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • Las Vegas Urology - Smoke Ranch
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • OptumCare Cancer Care at MountainView
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • Urology Specialists of Nevada - Northwest
      • Las Vegas, Nevada, Stati Uniti, 89135
        • Sospeso
        • Alliance for Childhood Diseases/Cure 4 the Kids Foundation
      • Las Vegas, Nevada, Stati Uniti, 89144
        • Sospeso
        • Comprehensive Cancer Centers of Nevada - Town Center
      • Las Vegas, Nevada, Stati Uniti, 89144
        • Sospeso
        • Comprehensive Cancer Centers of Nevada-Summerlin
      • Las Vegas, Nevada, Stati Uniti, 89144
        • Sospeso
        • Summerlin Hospital Medical Center
      • Las Vegas, Nevada, Stati Uniti, 89148-2405
        • Sospeso
        • Las Vegas Cancer Center-Medical Center
      • Las Vegas, Nevada, Stati Uniti, 89148
        • Sospeso
        • Comprehensive Cancer Centers of Nevada
      • Las Vegas, Nevada, Stati Uniti, 89169
        • Sospeso
        • Comprehensive Cancer Centers of Nevada - Central Valley
      • Las Vegas, Nevada, Stati Uniti, 89169
        • Sospeso
        • University Cancer Center
      • Las Vegas, Nevada, Stati Uniti, 89128
        • Sospeso
        • Oncology Las Vegas - Tenaya
      • Las Vegas, Nevada, Stati Uniti, 89183
        • Reclutamento
        • OptumCare Cancer Care at Fort Apache
        • Contatto:
        • Investigatore principale:
          • Khawaja S. Jahangir
      • Pahrump, Nevada, Stati Uniti, 89048
        • Sospeso
        • Hope Cancer Care of Nevada-Pahrump
      • Reno, Nevada, Stati Uniti, 89502
        • Sospeso
        • Renown Regional Medical Center
      • Reno, Nevada, Stati Uniti, 89503
        • Sospeso
        • Saint Mary's Regional Medical Center
      • Reno, Nevada, Stati Uniti, 89509
        • Sospeso
        • Radiation Oncology Associates
    • New Hampshire
      • Lebanon, New Hampshire, Stati Uniti, 03756
        • Reclutamento
        • Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
        • Contatto:
        • Investigatore principale:
          • Kathryn C. Hourdequin
    • New Jersey
      • Basking Ridge, New Jersey, Stati Uniti, 07920
        • Reclutamento
        • Memorial Sloan Kettering Basking Ridge
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • Camden, New Jersey, Stati Uniti, 08103
        • Reclutamento
        • Cooper Hospital University Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 856-325-6757
        • Investigatore principale:
          • Jamin C. Morrison
      • Middletown, New Jersey, Stati Uniti, 07748
        • Reclutamento
        • Memorial Sloan Kettering Monmouth
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • Montvale, New Jersey, Stati Uniti, 07645
        • Reclutamento
        • Memorial Sloan Kettering Bergen
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • Teaneck, New Jersey, Stati Uniti, 07666
        • Attivo, non reclutante
        • Holy Name Hospital
      • Voorhees Township, New Jersey, Stati Uniti, 08043
        • Reclutamento
        • MD Anderson Cancer Center at Cooper-Voorhees
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 856-325-6757
        • Investigatore principale:
          • Jamin C. Morrison
    • New Mexico
      • Albuquerque, New Mexico, Stati Uniti, 87110
        • Reclutamento
        • Presbyterian Kaseman Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 505-559-6113
          • Email: WBurman@phs.org
        • Investigatore principale:
          • Erika Maestas
      • Albuquerque, New Mexico, Stati Uniti, 87106
        • Reclutamento
        • University of New Mexico Cancer Center
        • Contatto:
        • Investigatore principale:
          • Erika Maestas
    • New York
      • Buffalo, New York, Stati Uniti, 14263
        • Reclutamento
        • Roswell Park Cancer Institute
        • Investigatore principale:
          • Kannan Thanikachalam
        • Contatto:
      • Commack, New York, Stati Uniti, 11725
        • Reclutamento
        • Memorial Sloan Kettering Commack
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • Greenlawn, New York, Stati Uniti, 11740
        • Reclutamento
        • Northwell Health Cancer Institute at Huntington
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 516-734-8896
        • Investigatore principale:
          • Daniel A. King
      • Harrison, New York, Stati Uniti, 10604
        • Reclutamento
        • Memorial Sloan Kettering Westchester
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • Lake Success, New York, Stati Uniti, 11042
        • Reclutamento
        • Northwell Health/Center for Advanced Medicine
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 516-734-8896
        • Investigatore principale:
          • Daniel A. King
      • Mineola, New York, Stati Uniti, 11501
        • Reclutamento
        • NYU Langone Hospital - Long Island
        • Contatto:
        • Investigatore principale:
          • Paul E. Oberstein
      • New York, New York, Stati Uniti, 10065
        • Reclutamento
        • Memorial Sloan Kettering Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • New York, New York, Stati Uniti, 10016
        • Reclutamento
        • Laura and Isaac Perlmutter Cancer Center at NYU Langone
        • Contatto:
        • Investigatore principale:
          • Paul E. Oberstein
      • Rochester, New York, Stati Uniti, 14621
        • Reclutamento
        • Rochester General Hospital
        • Contatto:
        • Investigatore principale:
          • Amy Bodrog
      • Rochester, New York, Stati Uniti, 14626
        • Reclutamento
        • Unity Park Ridge Campus
        • Contatto:
        • Investigatore principale:
          • Amy Bodrog
      • Uniondale, New York, Stati Uniti, 11553
        • Reclutamento
        • Memorial Sloan Kettering Nassau
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 212-639-7592
        • Investigatore principale:
          • Fiyinfolu Balogun
      • Williamsville, New York, Stati Uniti, 14221
        • Reclutamento
        • Roswell Park Amherst Center
        • Investigatore principale:
          • Kannan Thanikachalam
        • Contatto:
    • North Carolina
      • Clinton, North Carolina, Stati Uniti, 28328
        • Reclutamento
        • Southeastern Medical Oncology Center-Clinton
        • Contatto:
        • Investigatore principale:
          • Samer S. Kasbari
      • Goldsboro, North Carolina, Stati Uniti, 27534
        • Reclutamento
        • Southeastern Medical Oncology Center-Goldsboro
        • Contatto:
        • Investigatore principale:
          • Samer S. Kasbari
      • Jacksonville, North Carolina, Stati Uniti, 28546
        • Reclutamento
        • Southeastern Medical Oncology Center-Jacksonville
        • Investigatore principale:
          • Samer S. Kasbari
        • Contatto:
    • North Dakota
      • Bismarck, North Dakota, Stati Uniti, 58501
      • Fargo, North Dakota, Stati Uniti, 58122
      • Fargo, North Dakota, Stati Uniti, 58122
    • Ohio
      • Centerville, Ohio, Stati Uniti, 45459
        • Reclutamento
        • Miami Valley Hospital South
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Cincinnati, Ohio, Stati Uniti, 45220
        • Attivo, non reclutante
        • Good Samaritan Hospital - Cincinnati
      • Cincinnati, Ohio, Stati Uniti, 45242
        • Attivo, non reclutante
        • Bethesda North Hospital
      • Cincinnati, Ohio, Stati Uniti, 45247
        • Attivo, non reclutante
        • TriHealth Cancer Institute-Westside
      • Cincinnati, Ohio, Stati Uniti, 45255
        • Attivo, non reclutante
        • TriHealth Cancer Institute-Anderson
      • Dayton, Ohio, Stati Uniti, 45409
        • Reclutamento
        • Miami Valley Hospital
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Dayton, Ohio, Stati Uniti, 45415
        • Reclutamento
        • Miami Valley Hospital North
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Dayton, Ohio, Stati Uniti, 45409
        • Reclutamento
        • Premier Blood and Cancer Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 937-276-8320
        • Investigatore principale:
          • Tarek M. Sabagh
      • Dayton, Ohio, Stati Uniti, 45415
        • Attivo, non reclutante
        • Dayton Physician LLC - Englewood
      • Franklin, Ohio, Stati Uniti, 45005-1066
        • Reclutamento
        • Atrium Medical Center-Middletown Regional Hospital
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
      • Greenville, Ohio, Stati Uniti, 45331
        • Reclutamento
        • Miami Valley Cancer Care and Infusion
        • Investigatore principale:
          • Tarek M. Sabagh
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 937-569-7515
      • Kettering, Ohio, Stati Uniti, 45429
        • Attivo, non reclutante
        • Kettering Medical Center
      • Toledo, Ohio, Stati Uniti, 43623
        • Sospeso
        • Mercy Health - Saint Anne Hospital
      • Toledo, Ohio, Stati Uniti, 43623
        • Sospeso
        • Toledo Clinic Cancer Centers-Toledo
      • Troy, Ohio, Stati Uniti, 45373
        • Reclutamento
        • Upper Valley Medical Center
        • Contatto:
        • Investigatore principale:
          • Tarek M. Sabagh
    • Oklahoma
      • Oklahoma City, Oklahoma, Stati Uniti, 73120
        • Reclutamento
        • Mercy Hospital Oklahoma City
        • Investigatore principale:
          • Jay W. Carlson
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 405-752-3402
      • Oklahoma City, Oklahoma, Stati Uniti, 73104
        • Attivo, non reclutante
        • University of Oklahoma Health Sciences Center
    • Oregon
      • Bend, Oregon, Stati Uniti, 97701
        • Sospeso
        • Saint Charles Health System
      • Clackamas, Oregon, Stati Uniti, 97015
        • Sospeso
        • Clackamas Radiation Oncology Center
      • Clackamas, Oregon, Stati Uniti, 97015
        • Sospeso
        • Providence Cancer Institute Clackamas Clinic
      • Coos Bay, Oregon, Stati Uniti, 97420
        • Sospeso
        • Bay Area Hospital
      • Newberg, Oregon, Stati Uniti, 97132
        • Reclutamento
        • Providence Newberg Medical Center
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Oregon City, Oregon, Stati Uniti, 97045
        • Reclutamento
        • Providence Willamette Falls Medical Center
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Portland, Oregon, Stati Uniti, 97239
        • Reclutamento
        • Oregon Health and Science University
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 503-494-1080
          • Email: trials@ohsu.edu
        • Investigatore principale:
          • Charles D. Lopez
      • Portland, Oregon, Stati Uniti, 97213
        • Reclutamento
        • Providence Portland Medical Center
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Portland, Oregon, Stati Uniti, 97225
        • Reclutamento
        • Providence Saint Vincent Medical Center
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Redmond, Oregon, Stati Uniti, 97756
        • Sospeso
        • Saint Charles Health System-Redmond
    • Pennsylvania
      • Bryn Mawr, Pennsylvania, Stati Uniti, 19010
        • Sospeso
        • Bryn Mawr Hospital
      • Collegeville, Pennsylvania, Stati Uniti, 19426
        • Sospeso
        • Main Line Health Center-Collegeville
      • Exton, Pennsylvania, Stati Uniti, 19341
        • Sospeso
        • Main Line Health Center-Exton
      • Media, Pennsylvania, Stati Uniti, 19063
        • Reclutamento
        • Riddle Memorial Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 484-476-2649
          • Email: turzoe@mlhs.org
        • Investigatore principale:
          • Paul B. Gilman
      • Paoli, Pennsylvania, Stati Uniti, 19301
        • Reclutamento
        • Paoli Memorial Hospital
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 484-476-2649
          • Email: turzoe@mlhs.org
        • Investigatore principale:
          • Paul B. Gilman
      • Philadelphia, Pennsylvania, Stati Uniti, 19104
        • Reclutamento
        • University of Pennsylvania/Abramson Cancer Center
        • Investigatore principale:
          • Kim A. Reiss Binder
        • Contatto:
      • Philadelphia, Pennsylvania, Stati Uniti, 19111
        • Attivo, non reclutante
        • Fox Chase Cancer Center
      • Wynnewood, Pennsylvania, Stati Uniti, 19096
        • Reclutamento
        • Lankenau Medical Center
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 484-476-2649
          • Email: turzoe@mlhs.org
        • Investigatore principale:
          • Paul B. Gilman
    • South Dakota
      • Aberdeen, South Dakota, Stati Uniti, 57401
        • Reclutamento
        • Avera Cancer Institute-Aberdeen
        • Contatto:
        • Investigatore principale:
          • Heidi A. McKean
      • Pierre, South Dakota, Stati Uniti, 57501
        • Reclutamento
        • Avera Cancer Institute at Pierre
        • Contatto:
        • Investigatore principale:
          • Heidi A. McKean
      • Sioux Falls, South Dakota, Stati Uniti, 57104
        • Reclutamento
        • Sanford Cancer Center Oncology Clinic
        • Investigatore principale:
          • Daniel Almquist
        • Contatto:
      • Sioux Falls, South Dakota, Stati Uniti, 57117-5134
        • Reclutamento
        • Sanford USD Medical Center - Sioux Falls
        • Investigatore principale:
          • Daniel Almquist
        • Contatto:
      • Sioux Falls, South Dakota, Stati Uniti, 57105
        • Reclutamento
        • Avera Cancer Institute
        • Contatto:
        • Investigatore principale:
          • Heidi A. McKean
    • Tennessee
      • Collierville, Tennessee, Stati Uniti, 38017
        • Reclutamento
        • Baptist Memorial Hospital and Cancer Center-Collierville
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
      • Memphis, Tennessee, Stati Uniti, 38120
        • Reclutamento
        • Baptist Memorial Hospital and Cancer Center-Memphis
        • Contatto:
        • Investigatore principale:
          • Stephen W. Behrman
    • Texas
      • Bryan, Texas, Stati Uniti, 77802
        • Attivo, non reclutante
        • Saint Joseph Regional Cancer Center
      • Dallas, Texas, Stati Uniti, 75390
        • Reclutamento
        • UT Southwestern/Simmons Cancer Center-Dallas
        • Contatto:
        • Investigatore principale:
          • Victoria Chung
      • Dallas, Texas, Stati Uniti, 75235
        • Reclutamento
        • Parkland Memorial Hospital
        • Contatto:
        • Investigatore principale:
          • Victoria Chung
      • Dallas, Texas, Stati Uniti, 75237
        • Reclutamento
        • UT Southwestern Simmons Cancer Center - RedBird
        • Investigatore principale:
          • Victoria Chung
        • Contatto:
      • Fort Worth, Texas, Stati Uniti, 76104
        • Reclutamento
        • UT Southwestern/Simmons Cancer Center-Fort Worth
        • Contatto:
        • Investigatore principale:
          • Victoria Chung
      • Richardson, Texas, Stati Uniti, 75080
        • Reclutamento
        • UT Southwestern Clinical Center at Richardson/Plano
        • Contatto:
        • Investigatore principale:
          • Victoria Chung
    • Utah
      • Farmington, Utah, Stati Uniti, 84025
        • Reclutamento
        • Farmington Health Center
        • Contatto:
        • Investigatore principale:
          • Vaia Florou
      • Salt Lake City, Utah, Stati Uniti, 84106
        • Reclutamento
        • University of Utah Sugarhouse Health Center
        • Contatto:
        • Investigatore principale:
          • Vaia Florou
      • Salt Lake City, Utah, Stati Uniti, 84112
        • Reclutamento
        • Huntsman Cancer Institute/University of Utah
        • Contatto:
        • Investigatore principale:
          • Vaia Florou
    • Vermont
      • Saint Johnsbury, Vermont, Stati Uniti, 05819
        • Reclutamento
        • Dartmouth Cancer Center - North
        • Contatto:
        • Investigatore principale:
          • Kathryn C. Hourdequin
    • Washington
      • Aberdeen, Washington, Stati Uniti, 98520
        • Sospeso
        • Providence Regional Cancer System-Aberdeen
      • Auburn, Washington, Stati Uniti, 98001
        • Attivo, non reclutante
        • MultiCare Auburn Medical Center
      • Bellevue, Washington, Stati Uniti, 98004
        • Sospeso
        • Overlake Medical Center
      • Bellingham, Washington, Stati Uniti, 98225
        • Sospeso
        • PeaceHealth Saint Joseph Medical Center
      • Burien, Washington, Stati Uniti, 98166
        • Attivo, non reclutante
        • Saint Anne Hospital
      • Centralia, Washington, Stati Uniti, 98531
        • Sospeso
        • Providence Regional Cancer System-Centralia
      • Edmonds, Washington, Stati Uniti, 98026
        • Reclutamento
        • Swedish Cancer Institute-Edmonds
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Enumclaw, Washington, Stati Uniti, 98022
        • Attivo, non reclutante
        • Saint Elizabeth Hospital
      • Everett, Washington, Stati Uniti, 98201
        • Sospeso
        • Providence Regional Cancer Partnership
      • Federal Way, Washington, Stati Uniti, 98003
        • Attivo, non reclutante
        • Saint Francis Hospital
      • Gig Harbor, Washington, Stati Uniti, 98335
        • Attivo, non reclutante
        • MultiCare Gig Harbor Medical Park
      • Issaquah, Washington, Stati Uniti, 98029
        • Reclutamento
        • Swedish Cancer Institute-Issaquah
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Kennewick, Washington, Stati Uniti, 99336
        • Reclutamento
        • Kadlec Clinic Hematology and Oncology
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Lacey, Washington, Stati Uniti, 98503
        • Reclutamento
        • Providence Regional Cancer System-Lacey
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Lakewood, Washington, Stati Uniti, 98499
        • Attivo, non reclutante
        • Saint Clare Hospital
      • Longview, Washington, Stati Uniti, 98632
        • Sospeso
        • PeaceHealth Saint John Medical Center
      • Puyallup, Washington, Stati Uniti, 98372
        • Attivo, non reclutante
        • MultiCare Good Samaritan Hospital
      • Renton, Washington, Stati Uniti, 98055
        • Reclutamento
        • Valley Medical Center
        • Contatto:
        • Investigatore principale:
          • Khawaja S. Jahangir
      • Seattle, Washington, Stati Uniti, 98104
        • Sospeso
        • Pacific Gynecology Specialists
      • Seattle, Washington, Stati Uniti, 98107
        • Sospeso
        • Swedish Medical Center-Ballard Campus
      • Seattle, Washington, Stati Uniti, 98122-5711
        • Sospeso
        • Swedish Medical Center-Cherry Hill
      • Seattle, Washington, Stati Uniti, 98122
        • Reclutamento
        • Swedish Medical Center-First Hill
        • Investigatore principale:
          • Alison K. Conlin
        • Contatto:
      • Sedro-Woolley, Washington, Stati Uniti, 98284
        • Sospeso
        • PeaceHealth United General Medical Center
      • Shelton, Washington, Stati Uniti, 98584
        • Sospeso
        • Providence Regional Cancer System-Shelton
      • Silverdale, Washington, Stati Uniti, 98383
        • Attivo, non reclutante
        • Saint Joseph Medical Center Hematology and Oncology - Silverdale
      • Spokane, Washington, Stati Uniti, 99204
        • Attivo, non reclutante
        • MultiCare Deaconess Cancer and Blood Specialty Center - Downtown
      • Spokane, Washington, Stati Uniti, 99218
        • Attivo, non reclutante
        • MultiCare Deaconess Cancer and Blood Specialty Center - North
      • Spokane Valley, Washington, Stati Uniti, 99216
        • Sospeso
        • MultiCare Deaconess Cancer and Blood Specialty Center - Valley
      • Tacoma, Washington, Stati Uniti, 98405
        • Attivo, non reclutante
        • MultiCare Tacoma General Hospital
      • Tacoma, Washington, Stati Uniti, 98405
        • Attivo, non reclutante
        • Franciscan Research Center-Northwest Medical Plaza
      • Vancouver, Washington, Stati Uniti, 98664
        • Sospeso
        • PeaceHealth Southwest Medical Center
      • Walla Walla, Washington, Stati Uniti, 99362
        • Sospeso
        • Providence Saint Mary Regional Cancer Center
      • Yakima, Washington, Stati Uniti, 98902
        • Sospeso
        • North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
      • Yelm, Washington, Stati Uniti, 98597
        • Sospeso
        • Providence Regional Cancer System-Yelm
    • West Virginia
      • Bridgeport, West Virginia, Stati Uniti, 26330
        • Reclutamento
        • United Hospital Center
        • Contatto:
        • Investigatore principale:
          • Nour Daboul
      • Morgantown, West Virginia, Stati Uniti, 26506
        • Reclutamento
        • West Virginia University Healthcare
        • Contatto:
        • Investigatore principale:
          • Nour Daboul
      • Parkersburg, West Virginia, Stati Uniti, 26101
        • Reclutamento
        • Camden Clark Medical Center
        • Contatto:
        • Investigatore principale:
          • Nour Daboul
    • Wisconsin
      • Appleton, Wisconsin, Stati Uniti, 54911
        • Reclutamento
        • ThedaCare Regional Cancer Center
        • Contatto:
        • Investigatore principale:
          • Matthias Weiss
      • Eau Claire, Wisconsin, Stati Uniti, 54701
      • Green Bay, Wisconsin, Stati Uniti, 54301
        • Reclutamento
        • Saint Vincent Hospital Cancer Center Green Bay
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Green Bay, Wisconsin, Stati Uniti, 54303
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Saint Mary's
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Janesville, Wisconsin, Stati Uniti, 53548
        • Reclutamento
        • Mercyhealth Hospital and Cancer Center - Janesville
        • Contatto:
        • Investigatore principale:
          • Emily G. Robinson
      • Johnson Creek, Wisconsin, Stati Uniti, 53038
        • Reclutamento
        • University of Wisconsin Carbone Cancer Center - Johnson Creek
        • Investigatore principale:
          • Monica A. Patel
        • Contatto:
      • La Crosse, Wisconsin, Stati Uniti, 54601
        • Reclutamento
        • Gundersen Lutheran Medical Center
        • Contatto:
        • Investigatore principale:
          • Kurt Oettel
      • Madison, Wisconsin, Stati Uniti, 53792
        • Reclutamento
        • University of Wisconsin Carbone Cancer Center - University Hospital
        • Investigatore principale:
          • Monica A. Patel
        • Contatto:
      • Madison, Wisconsin, Stati Uniti, 53718
        • Reclutamento
        • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center
        • Investigatore principale:
          • Monica A. Patel
        • Contatto:
      • Marshfield, Wisconsin, Stati Uniti, 54449
      • Minocqua, Wisconsin, Stati Uniti, 54548
      • Mukwonago, Wisconsin, Stati Uniti, 53149
        • Reclutamento
        • ProHealth D N Greenwald Center
        • Contatto:
        • Investigatore principale:
          • Timothy R. Wassenaar
      • New Richmond, Wisconsin, Stati Uniti, 54017
        • Reclutamento
        • Cancer Center of Western Wisconsin
        • Contatto:
        • Investigatore principale:
          • David M. King
      • Oconomowoc, Wisconsin, Stati Uniti, 53066
        • Reclutamento
        • ProHealth Oconomowoc Memorial Hospital
        • Investigatore principale:
          • Timothy R. Wassenaar
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 262-928-7878
      • Oconto Falls, Wisconsin, Stati Uniti, 54154
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Oconto Falls
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Rice Lake, Wisconsin, Stati Uniti, 54868
      • Sheboygan, Wisconsin, Stati Uniti, 53081
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Sheboygan
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Stevens Point, Wisconsin, Stati Uniti, 54482
      • Sturgeon Bay, Wisconsin, Stati Uniti, 54235-1495
        • Reclutamento
        • Saint Vincent Hospital Cancer Center at Sturgeon Bay
        • Investigatore principale:
          • Brian L. Burnette
        • Contatto:
      • Waukesha, Wisconsin, Stati Uniti, 53188
        • Reclutamento
        • ProHealth Waukesha Memorial Hospital
        • Investigatore principale:
          • Timothy R. Wassenaar
        • Contatto:
          • Site Public Contact
          • Numero di telefono: 262-928-7632
      • Waukesha, Wisconsin, Stati Uniti, 53188
        • Reclutamento
        • UW Cancer Center at ProHealth Care
        • Investigatore principale:
          • Timothy R. Wassenaar
        • Contatto:
      • Weston, Wisconsin, Stati Uniti, 54476

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • STEP 0 (PRE-REGISTRATION) INCLUSION CRITERIA

  • Patient must be >= 18 years of age on day of consent

  • Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

  • Patient must have a diagnosis of pancreatic cancer and have successfully undergone a curative intent surgical resection and must have no evidence of recurrent disease as determined by the investigator

    • NOTE: This includes patients with adenocarcinoma, acinar carcinoma, squamous cell carcinoma adenosquamous and variants thereof. Patients with neuroendocrine tumors are excluded from enrolling
  • Patient must (1) be planning to receive, (2) be receiving or (3) have received at least three combined months (i.e., 12 weeks) of perioperative (neoadjuvant, adjuvant or a combination of both) systemic, multi-agent chemotherapy. Patients may have had up to 6 months of perioperative systemic therapy as deemed appropriate by their primary treating medical team (patients can have received radiation or chemoradiation in addition to this 6 month course)

  • Patient must be no more than 12 weeks from their most recent treatment (this may be chemotherapy, radiotherapy or surgery)

  • Patient must have a known pathogenic or likely pathogenic germline or somatic mutation in BRCA1, BRCA2, or PALB2, as determined by a Clinical Laboratory Improvement Amendments (CLIA) certified or equivalently-accredited laboratory. Mutations must be considered pathogenic or likely pathogenic by a reference database such as ClinVar or OncoKb.org

  • STEP 1 (RANDOMIZATION) INCLUSION CRITERIA

  • Patient must have met the eligibility criteria outlined above

  • Patient must have undergone at least 3 combined months (i.e., 12 weeks) of perioperative (neoadjuvant, adjuvant or a combination of both) systemic, multi-agent chemotherapy. Patients may have had up to 6 months of perioperative systemic therapy as deemed appropriate by their primary treating medical team (patients can have received radiation or chemoradiation in addition to this 6 months course)

  • Central expert reviewer must have determined the patient eligible for randomization after review of local genetic testing reports

  • If mutation in BRCA1, BRCA2 or PALB2 was identified in tumor tissue and the patient has not previously undergone germline testing, the patient must agree to undergo germline testing

  • Patient must have no evidence of recurrent or metastatic pancreatic cancer at the time of randomization as documented by baseline scans obtained =< 4 weeks prior to Step 1 randomization

  • Patient must not have previously had evidence of progressive pancreatic cancer while receiving platinum-based therapy

  • Patient must be >= 21 days (three weeks) from their last treatment (including chemotherapy radiotherapy or surgery) but =< 84 days (twelve weeks) from their last treatment at the time of Step 1 randomization. Patients who have received neoadjuvant and/or adjuvant radiotherapy are eligible

  • Patient must have recovered from any adverse events due to prior anti-cancer therapy (i.e., have no residual toxicities > grade 1 with the exception of alopecia and/or neuropathy)

  • Patient must not be receiving any other investigational agents at the time of Step 1 randomization and while on protocol treatment

  • Patient must not have any history of allergic reactions attributed to compounds of similar chemical or biological composition to olaparib

  • Patient must not have any personal history of myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). Patients with myelodysplastic syndrome/acute myeloid leukemia or with features suggestive of MDS/AML

  • Patient must not have any uncontrolled gastrointestinal disorder that would, in the opinion of the investigator, interfere with the ingestion or absorption of olaparib

  • Patient must not be pregnant or breast-feeding due the potential harm to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used. All patients of childbearing potential must have a blood test or urine study within 14 days prior to Step 1 randomization to rule out pregnancy. A patient of childbearing potential is defined as anyone, regardless of whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)

  • Patients must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for the duration of their participation in the study and for 6 months after the last dose of protocol treatment for female patients and for 3 months after the last dose of protocol treatment for male patients. Patients must also not donate sperm while on protocol treatment and for 3 months after the last dose of protocol treatment. Patients must also not breast-feed while on protocol treatment and for 1 month after the last dose of protocol treatment

  • Leukocytes >= 3,000/mcL (obtained =< 28 days prior to Step 1 randomization)

  • Absolute neutrophil count >= 1,500/mcL (obtained =< 28 days prior to Step 1 randomization)

  • Platelets >= 100,000/mcL (obtained =< 28 days prior to Step 1 randomization)

  • Hemoglobin >= 9.0 g/dL with no blood transfusion in the past 28 days (obtained =< 28 days prior to Step 1 randomization)

  • Total bilirubin =< 1.5 institutional upper limit of normal (ULN) except in patients with Gilbert's syndrome. Patients with Gilbert's syndrome may enroll if direct bilirubin =< 2.5 x ULN of the direct bilirubin (obtained =< 28 days prior to Step 1 randomization)

  • Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x institutional ULN (obtained =< 28 days prior to Step 1 randomization)

  • Creatinine =< 1.5 institutional ULN OR calculated Cockcroft Gault creatinine clearance > 50 mL/min/1.73 m^2 (obtained =< 28 days prior to Step 1 randomization)

  • Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial

  • For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated

  • Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load

  • Patient must not have resting electrocardiogram (ECG) indicating uncontrolled, potentially reversible cardiac conditions, as judged by the investigator (e.g. unstable ischemia, uncontrolled symptomatic arrhythmia, congestive heart failure, corrected QT [QTc] prolongation > 500 ms, electrolyte disturbances, etc.) or have congenital long QT syndrome

  • Concomitant use of known potent CYP3A4/5 inhibitors such as ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, telithromycin, clarithromycin and nelfinavir is prohibited

  • Patients who are being actively treated for an ongoing concurrent malignancy are ineligible, with the exception of those receiving adjuvant hormone therapies and those receiving topical therapies for skin cancers

  • Patient must not have, in the opinion of the investigator, any other concurrent medical condition that would prevent the patient from complying with the study procedures

  • Patient must not be considered a poor medical risk due to a serious, uncontrolled medical disorder, non-malignant systemic disease or active, uncontrolled infection. Examples include, but are not limited to, uncontrolled ventricular arrhythmia, recent (within 3 months) myocardial infarction, uncontrolled major seizure disorder, unstable spinal cord compression, superior vena cava syndrome, extensive interstitial bilateral lung disease on high resolution computed tomography (HRCT) scan or any psychiatric disorder that prohibits obtaining informed consent

  • Patient must have the ability to understand and the willingness to sign a written informed consent document, or have legally authorized representative provide authorization to participate

  • Patient must not have had major surgery within 2 weeks prior to Step 1 randomization and patients must have recovered from any effects of any major surgery

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Doppio

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Arm I (olaparib)

Patients receive olaparib PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for 12 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo CT scans or CT/MRI and collection of blood throughout the study.

Undergo collection of blood

Altri nomi:
  • Raccolta di campioni biologici
  • Biocampione raccolto
  • Raccolta di campioni
  • Raccolta campione

Given PO

Altri nomi:
  • Lynparz
  • AZD 2281
  • AZD-2281
  • AZD2281
  • KU-0059436
  • Inibitore PARP AZD2281
  • KU0059436
  • Olanib
  • Olaparix

Undergo CT or CT/MRI

Altri nomi:
  • CT
  • GATTO
  • TAC
  • Tomografia assiale computerizzata
  • Tomografia computerizzata
  • tomografia
  • Tomografia assiale computerizzata (procedura)
  • Scansione tomografia computerizzata (CT).
  • Scansione CAT diagnostica
  • Tipo di servizio di scansione CAT diagnostica

Undergo CT/MRI

Altri nomi:
  • Risonanza magnetica
  • Scansione di immagini a risonanza magnetica
  • Imaging medico, risonanza magnetica/risonanza magnetica nucleare
  • SIG
  • Imaging RM
  • Scansione MRI
  • Imaging NMR
  • RMN
  • Risonanza Magnetica Nucleare
  • Imaging a risonanza magnetica (MRI)
  • sMRI
  • Imaging a risonanza magnetica (procedura)
  • RM strutturale
Comparatore placebo: Arm II (placebo)

Patients receive placebo PO BID on days 1-28 of each cycle. Cycles repeat every 28 days for 12 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo CT scans or CT/MRI and collection of blood throughout the study.

Undergo collection of blood

Altri nomi:
  • Raccolta di campioni biologici
  • Biocampione raccolto
  • Raccolta di campioni
  • Raccolta campione

Given PO

Undergo CT or CT/MRI

Altri nomi:
  • CT
  • GATTO
  • TAC
  • Tomografia assiale computerizzata
  • Tomografia computerizzata
  • tomografia
  • Tomografia assiale computerizzata (procedura)
  • Scansione tomografia computerizzata (CT).
  • Scansione CAT diagnostica
  • Tipo di servizio di scansione CAT diagnostica

Undergo CT/MRI

Altri nomi:
  • Risonanza magnetica
  • Scansione di immagini a risonanza magnetica
  • Imaging medico, risonanza magnetica/risonanza magnetica nucleare
  • SIG
  • Imaging RM
  • Scansione MRI
  • Imaging NMR
  • RMN
  • Risonanza Magnetica Nucleare
  • Imaging a risonanza magnetica (MRI)
  • sMRI
  • Imaging a risonanza magnetica (procedura)
  • RM strutturale

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Improvement in relapse-free survival (RFS)
Lasso di tempo: From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed from 22 months to 44 months

Will demonstrate an improvement in the RFS from 22 months to 44 months (hazard ratio 0.5) in patients treated with olaparib after perioperative (neoadjuvant, adjuvant or a combination) chemotherapy compared to those treated with perioperative therapy alone.

From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed from 22 months to 44 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
RFS
Lasso di tempo: From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed up to 5 years

Will evaluate RFS in patients with olaparib after perioperative chemotherapy compared to those treated with perioperative therapy alone among patients who received prior platinum-based perioperative chemotherapy. Analysis will be largely exploratory. Within each arm any proportion endpoint (toxicity, mutation rate, etc.) will be estimable with a 95% confidence interval. Arm A would have a confidence interval that is 20 percentage points wide, and Arm B would have a confidence interval that is 29 percentage points wide.

From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed up to 5 years
Overall survival (OS)
Lasso di tempo: From randomization until 10 years after registration or until death, whichever comes first

Analysis will be largely exploratory. Power for overall survival in particular will be limited. Within each arm any proportion endpoint (toxicity, mutation rate, etc.) will be estimable with a 95% confidence interval. Arm A would have a confidence interval that is 20 percentage points wide, and Arm B would have a confidence interval that is 29 percentage points wide.

From randomization until 10 years after registration or until death, whichever comes first
Efficacy of olaparib after chemotherapy in patients with a pathogenic germline BRCA or PALB2 mutation
Lasso di tempo: Up to 10 years

Will analyze the efficacy of olaparib after chemotherapy in patients with a pathogenic germline BRCA or PALB2 mutation compared to those with a somatic mutation.

Up to 10 years
Differences in survival
Lasso di tempo: Up to 10 years

Will analyze survival differences between patients who received neoadjuvant or perioperative chemotherapy compared to those who received adjuvant therapy alone.

Up to 10 years
RFS in those who received =< 3 months of perioperative platinum chemotherapy compared to > 3 months of perioperative platinum chemotherapy
Lasso di tempo: From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed up to 5 years

Analysis will be largely exploratory. Within each arm any proportion endpoint (toxicity, mutation rate, etc.) will be estimable with a 95% confidence interval. Arm A would have a confidence interval that is 20 percentage points wide, and Arm B would have a confidence interval that is 29 percentage points wide.

From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed up to 5 years
OS in those who received =< 3 months of perioperative platinum chemotherapy versus > 3 months of perioperative platinum chemotherapy
Lasso di tempo: From randomization until 10 years after registration or until death, whichever comes first

Analysis will be largely exploratory. Power for overall survival in particular will be limited. Within each arm any proportion endpoint (toxicity, mutation rate, etc.) will be estimable with a 95% confidence interval. Arm A would have a confidence interval that is 20 percentage points wide, and Arm B would have a confidence interval that is 29 percentage points wide.

From randomization until 10 years after registration or until death, whichever comes first
RFS in those who received any platinum-based perioperative chemotherapy versus no platinum-based perioperative chemotherapy
Lasso di tempo: From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed up to 5 years

Analysis will be largely exploratory. Within each arm any proportion endpoint (toxicity, mutation rate, etc.) will be estimable with a 95% confidence interval. Arm A would have a confidence interval that is 20 percentage points wide, and Arm B would have a confidence interval that is 29 percentage points wide.

From randomization to first documentation of disease recurrence (primary tumor relapse) or death, assessed up to 5 years
OS in those who received any platinum-based perioperative chemotherapy versus no platinum-based perioperative chemotherapy
Lasso di tempo: From randomization until 10 years after registration or until death, whichever comes first

Analysis will be largely exploratory. Power for overall survival in particular will be limited. Within each arm any proportion endpoint (toxicity, mutation rate, etc.) will be estimable with a 95% confidence interval. Arm A would have a confidence interval that is 20 percentage points wide, and Arm B would have a confidence interval that is 29 percentage points wide.

From randomization until 10 years after registration or until death, whichever comes first

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Differenze di RFS e OS nei pazienti sottoposti a resezioni R1 vs R0
Lasso di tempo: Fino a 10 anni
Fino a 10 anni
Differenze di RFS e OS nei pazienti che presentavano positività linfonodale alla resezione
Lasso di tempo: Fino a 10 anni
Fino a 10 anni
RFS and OS differences in patients who had elevated or rising CA 19-9 or CEA
Lasso di tempo: Up to 10 years

A cutoff of 35 will be used to determine elevated versus normal CA 19-9 (i.e., greater than 35 will be considered elevated), and the cutoff for CEA will be based on the treating institution's definition of the upper limit of normal. Univariate differences by marker status will be analyzed and Cox proportional hazards models will be fit, adjusting for other clinical and demographic factors that may be confounders.

Up to 10 years
RFS and OS differences with those who had resectable disease at diagnosis
Lasso di tempo: Up to 10 years

Will be compared to those who did not.

Up to 10 years

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Kim A Reiss Binder, ECOG-ACRIN Cancer Research Group

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

22 giugno 2021

Completamento primario (Stimato)

31 ottobre 2027

Completamento dello studio (Stimato)

31 ottobre 2027

Date di iscrizione allo studio

Primo inviato

23 aprile 2021

Primo inviato che soddisfa i criteri di controllo qualità

23 aprile 2021

Primo Inserito (Effettivo)

26 aprile 2021

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

18 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

17 novembre 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • NCI-2020-05659
  • U10CA180820 (Sovvenzione/contratto NIH degli Stati Uniti)
  • NCI-2020-05659 (Identificatore di registro: CTRP (Clinical Trial Reporting Program))
  • EA2192 (Altro identificatore: CTEP)
  • EA2192 (Altro identificatore: ECOG-ACRIN Cancer Research Group)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

Sì

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .